Luca Castelnovo

Dr. Luca Castelnovo

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Neural Regeneration Research
Verified
Journal Article
Open access
PDF file
Valerio MagnaghiValerio Magnaghi
Valerio Magnaghi
LCLuca Castelnovo
Luca Castelnovo
Veronica BonalumeVeronica Bonalume
Veronica Bonalume
SMSimona Melfi
Simona Melfi
MBMarinella Ballabio
Marinella Ballabio
DCDeborah Colleoni
Deborah Colleoni
The development, maturation and regeneration of Schwann cells (SCs), the main glial cells of the peripheral nervous system, require the coordinate and complementary interaction among several factors, signals and intracellular pathways. These regulatory molecules consist of integrins, neuregulins, growth factors, hormones, neurotransmitters, as well as entire intracellular pathways including protein-kinase A, C, Akt, Erk/MAPK, Hippo, mTOR, etc. For instance, Hippo pathway is overall involved in proliferation, apoptosis, regeneration and organ size control, being crucial in cancer proliferation process. In SCs, Hippo is linked to merlin and YAP/TAZ signaling and it seems to respond to mechanic/physical challenges. Recently, among factors regulating SCs, also the signaling intermediates Src tyrosine kinase and focal adhesion kinase (FAK) proved relevant for SC fate, participating in the regulation of adhesion, motility, migration and in vitro myelination. In SCs, the factors Src and FAK are regulated by the neuroactive steroid allopregnanolone, thus corroborating the importance of this steroid in the control of SC maturation. In this review, we illustrate some old and novel signaling pathways modulating SC biology and functions during the different developmental, mature and regenerative states

29 January 2014 in Glia
Verified
Journal Article
Closed access
PDF file
AFAlessandro Faroni
Alessandro Faroni
LCLuca Castelnovo
Luca Castelnovo
PPProcacci Patrizia
Procacci Patrizia
LCLucia Caffino
Lucia Caffino
FFFabio Fumagalli
Fabio Fumagalli
Valerio MagnaghiValerio Magnaghi
Valerio Magnaghi

5 June 2014 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
AFAlessandro Faroni
Alessandro Faroni
RSR.J.P. Smith
R.J.P. Smith
PPProcacci Patrizia
Procacci Patrizia
LCLuca Castelnovo
Luca Castelnovo
EPE. Puccianti
E. Puccianti
Alexei VerkhratskyAlexei Verkhratsky
Alexei Verkhratsky

20 November 2019 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
LCLuca Castelnovo
Luca Castelnovo
LCLucia Caffino
Lucia Caffino
Veronica BonalumeVeronica Bonalume
Veronica Bonalume
FFFabio Fumagalli
Fabio Fumagalli
PTPeter Thomas
Peter Thomas
Valerio MagnaghiValerio Magnaghi
Valerio Magnaghi

30 August 2022 in Endocrinology
Verified
Journal Article
Closed access
PDF file
PTPeter Thomas
Peter Thomas
YPYefei Pang
Yefei Pang
MCMaria Andrea Camilletti
Maria Andrea Camilletti
LCLuca Castelnovo
Luca Castelnovo
Gender differences in a wide variety of physiological parameters have implicated the ovarian hormones, estrogens and progesterone, in the regulation of numerous nonreproductive tissue functions. Rapid, nongenomic (nonclassical) progesterone actions mediated by membrane progesterone receptors (mPRs), which belong to the progestin and adipoQ receptor family, have been extensively investigated in reproductive and nonreproductive tissues since their discovery in fish ovaries 20 years ago. The 5 mPR subtypes (α, β, γ, δ, ε) are widely distributed in vertebrate tissues and are often expressed in the same cells as the nuclear progesterone receptor (PR) and progesterone receptor membrane component 1, thereby complicating investigations of mPR-specific functions. Nevertheless, mPR-mediated progesterone actions have been identified in a wide range of reproductive and nonreproductive tissues and distinguished from nuclear PR-mediated ones by knockdown of these receptors with siRNA in combination with a pharmacological approach using mPR- and PR-specific agonists. There are several recent reviews on the roles of the mPRs in vertebrate reproduction and cancer, but there have been no comprehensive assessments of mPR functions in nonreproductive tissues. Therefore, this article briefly reviews mPR functions in a broad range of nonreproductive tissues. The evidence that mPRs mediate progesterone and progestogen effects on neuroprotection, lordosis behavior, respiratory control of apnea, olfactory responses to pheromones, peripheral nerve regeneration, regulation of prolactin secretion in prolactinoma, immune functions, and protective functions in vascular endothelial and smooth muscle cells is critically reviewed. The ubiquitous expression of mPRs in vertebrate tissues suggests mPRs regulate many additional nonreproductive functions that remain to be identified.